13 Paid Clinical Research Studies in Phoenix, Arizona

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

This clinical trial studies how well intensity modulated proton therapy (IMPT) or intensity modulated X-ray (radiation) therapy (IMRT) works after surgery in treating patients with

📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona

💵 Patients may receive cisplatin intravenously (IV) over 1-2 hours per standard of care.

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

This is an open-label, multi-center Phase 0 study with an expansion phase that will enroll up to 24 participants with newly-diagnosed glioblastoma and up to 18 recurrent glioma par

📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona

💵 Participants may receive erythrocyte transfusions to achieve this hemoglobin level at the discretion of the investigator

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

A pilot pharmacokinetic trial to determine the safety and efficacy of a flavored, orally administered irinotecan VAL-413 (Orotecan®) given with temozolomide for treatment of recurr

📍 Phoenix Children's Hospital — Phoenix, Arizona

💵 During the first cycle of treatment, each patient will receive 4 daily doses of VAL-413 (Orotecan®) and one daily dose o

Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial

The goal of this clinical trial is to develop an effective internet-delivered program to help breast cancer survivors manage cancer-related sexual concerns. This study is being do

📍 Cancer Center at Saint Joseph's — Phoenix, Arizona

💵 Participants will receive a certain combination of these four different Cores to make up their SHINE program.

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

The primary objectives of this study are to evaluate progression-free survival (PFS) by blinded independent central review (BICR) and overall survival (OS) (evaluated independently

📍 Site 318 — Phoenix, Arizona

💵 Patients will receive study treatment until confirmed progressive disease (PD) or unacceptable toxicity.

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under t

📍 Medical Dermatology Specialists /ID# 240641 — Phoenix, Arizona

💵 In the Main Study, participants will receive subcutaneous injections of lutikizumab (ABT-981) or placebo every week for

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

This study will determine whether electrical stimulation of an area of the brain called the dorsolateral prefrontal cortex, which is important in determining the feeling of fullnes

📍 NIDDK, Phoenix — Phoenix, Arizona

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis

📍 Medical Dermatology Specialists (Phoenix) — Phoenix, Arizona

💵 The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibu

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Cenobamate (YKP3089) is a small molecule approved in the United States (US), Europe and several other countries around the world for the treatment of Partial-Onset (focal) seizures

📍 Arizona Neuroscience Research — Phoenix, Arizona

💵 During the 2-week Titration Phase, subjects will receive cenobamate 150 mg/day before entering the 26-week 200 mg/day Ma

Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

The purpose of this investigation is to evaluate the safety and superior effectiveness in functional improvement in patients with partial-thickness rotator cuff tears (PTRCTs) afte

📍 Arizona Research Center — Phoenix, Arizona

Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis

The goal of this clinical trial is to examine the effect of a single autologous, intra-articular injection of MFat versus saline injection for the treatment of pain and function as

📍 Arizona Bone, Joint and Sports Medicine Center LLC — Phoenix, Arizona

💵 Participants will receive an injection of MFat or saline.

Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta

The primary objective of the study is to evaluate the effect of setrusumab vs intravenous bisphosphonates (IV-BP) on reduction in fracture rate, including morphometric vertebral fr

📍 Phoenix Children's Hospital — Phoenix, Arizona

💵 Following randomization, participants will receive setrusumab or IV-BP for up to 24 months during the Active-controlled

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Fractyl is evaluating Revita Duodenal Mucosal Resurfacing (DMR) in the REMAIN-1 pivotal study, which is designed to include two cohorts - an open label cohort referred to as REVEAL

📍 Helios Clinical Research — Phoenix, Arizona

💵 Eligible participants will receive an open-label, tirzepatide run-in, dose-escalation period of approximately 16-26 week